Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Scher
    Scher
  2. Motzer
    Motzer
  3. Bajorin
    Bajorin
  4. Sheinfeld
    Sheinfeld
  5. Morris
    Morris
  6. Feldman
    Feldman
  7. Rosenberg
    Rosenberg
  8. D'Angelica
    D'Angelica
  9. Russo
    Russo
  10. Gonen
    Gonen

Groups

  1. Department of Medicine (579)
  2. Solid Tumor Oncology Division (579)
  3. Genitourinary Oncology Service (303)
  4. Surgery (164)
  5. Survivorship Research (123)
  6. GSK Faculty (100)
  7. Gastrointestinal Oncology Service (98)
  8. Urology (93)
  9. Epidemiology and Biostatistics (77)
  10. Center for Pancreatic Cancer Research (71)
Search Within
  1. "Solid Tumor Oncology Division"
  2. "Journal article"
Formats
  1. Journal Article (579)
Groups
  1. Department of Medicine (579)
  2. Solid Tumor Oncology Division (579)
  3. Genitourinary Oncology Service (303)
  4. Surgery (164)
  5. Survivorship Research (123)
  6. GSK Faculty (100)

More Groups

People
  1. Howard Scher (108)
  2. Robert Motzer (88)
  3. Dean Bajorin (49)
  4. Joel Sheinfeld (32)
  5. Victor Reuter (31)
  6. George Bosl (30)

More People

Years
  1. 2024 (7)
  2. 2023 (31)
  3. 2022 (26)
  4. 2021 (33)
  5. 2020 (37)
  6. 2019 (24)

More Years

Publications
  1. Lancet Oncology (165)
  2. Journal of Urology (93)
  3. European Urology (76)
  4. Urology (51)
  5. Lancet (38)
  6. Annals of Thoracic Surgery (19)

More Publications

Results (579)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Incremental utility of first-pass perfusion CMR for prognostic risk stratification of cancer-associated cardiac masses
    Journal Article

    Chan, A. T.; Maya, T. R.; Park, C.; Tak, K.; Liberman, N.; Jain, R. H.; Park, M. J.; Park, R. Y.; Grizzard, J.; Kim, G.; more...
    JACC: Cardiovascular Imaging (2024)

    Fulltext@MSK | Save
  • Safety analyses of the phase 3 VISION trial of [(177)Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Journal Article

    Chi, K. N.; Armstrong, A. J.; Krause, B. J.; Herrmann, K.; Rahbar, K.; de Bono, J. S.; Adra, N.; Garje, R.; Michalski, J. M.; Kempel, M. M.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): Primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
    Journal Article

    Smit, E. F.; Felip, E.; Uprety, D.; Nagasaka, M.; Nakagawa, K.; Paz-Ares Rodríguez, L.; Pacheco, J. M.; Li, B. T.; Planchard, D.; Baik, C.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): An interim analysis of the multicentre, double-blind, randomised phase 3 study
    Journal Article

    Shitara, K.; Rha, S. Y.; Wyrwicz, L. S.; Oshima, T.; Karaseva, N.; Osipov, M.; Yasui, H.; Yabusaki, H.; Afanasyev, S.; Park, Y. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Yttrium-90 transarterial radioembolization of primary lung cancer metastases to the liver
    Journal Article

    Alexander, E. S.; Petre, E. N.; Zhao, K.; Sotirchos, V.; Namakydoust, A.; Moussa, A.; Yuan, G.; Sofocleous, C. T.; Solomon, S. B.; Ziv, E.
    Journal of Vascular and Interventional Radiology (2024)

    Fulltext@MSK | Save
  • Primary retroperitoneal lymph node dissection for seminoma metastatic to the retroperitoneum
    Journal Article

    Matulewicz, R. S.; Benfante, N.; Funt, S. A.; Feldman, D. R.; Carver, B.; Doudt, A.; Knezevic, A.; Sheinfeld, J.
    Journal of Urology (2024)

    Fulltext@MSK | Save
  • Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: Interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
    Journal Article

    Janjigian, Y. Y.; Kawazoe, A.; Bai, Y.; Xu, J.; Lonardi, S.; Metges, J. P.; Yanez, P.; Wyrwicz, L. S.; Shen, L.; Ostapenko, Y.; more...
    Lancet (2023)

    Fulltext@MSK | Save
  • Prognostic value of circumferential radial margin involvement in esophagectomy for esophageal cancer: A case series
    Journal Article

    Boerner, T.; Carr, R.; Hsu, M.; Tan, K. S.; Sigel, C.; Tang, L.; Harrington, C.; Ku, G. Y.; Ilson, D. H.; Janjigian, Y. Y.; more...
    International Journal of Surgery (2023)

    Fulltext@MSK | Save
  • Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): A randomised, open-label, multicentre, phase 3 trial
    Journal Article

    Rugo, H S.; Bardia, A.; Marmé, F.; Cortés, J.; Schmid, P.; Loirat, D.; Trédan, O.; Ciruelos, E.; Dalenc, F.; Gómez Pardo, P.; more...
    Lancet (2023)

    Fulltext@MSK | Save